BackProQR Therapeutics N.V Overview

ProQR Therapeutics N.V EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PRQR.

Quarterly EBIT

-$13.87M
↓ 28.27% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$46.45M
↓ 55.15% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin